Program start date: April 26, 2021
Target patients:
Patients of Hong Kong Hospital Authority who require ADAMTS13 test
Application criteria:
1. Valid HKID card holder
2. Patient of public hospitals of Hospital Authority of Hong Kong
3. With ADAMTS13 test referral letter from public hospitals of Hospital Authority of Hong Kong within program period from 26 April 2021 to 31 March 2023
4. Never received Eculizumab treatment
Please contact SafeMed Dispensary at 2979 0380 for enquiries about the program details.